Patent · US Active

Tartrate derivatives for use as coagulation factor IXa inhibitors

US8263621B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

Sanofi · FR

Inventors

Henning Steinhagen · Pocking, DE
Markus Follmann
Jochen Goerlitzer · Frankfurt am Main, DE
Herman Schreuder · Frankfurt am Main, DE

Key dates

Filing date	Mar 9, 2009
Grant date	Sep 11, 2012
Priority date	—
Expiry date	Mar 13, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the compounds of formula Ihaving antithrombotic activity which especially inhibits blood clotting factor IXa, to methods for producing the same and to the use thereof as drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.